Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
0.00%
)
US TECH 100
24,098.80
(
0.35%
)
Dow Jones
46,946.41
(
0.00%
)
Brent Oil
99.84
(
1.56%
)
Bitcoin
73,720.01
(
-1.50%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rwdm

Send PM Follow Ignore
Followers 1
Posts 132
Boards Moderated 0
Alias Born 07/19/2010

rwdm

Re: DewDiligence post# 99361

Tuesday, 07/27/2010 12:10:04 PM

Tuesday, July 27, 2010 12:10:04 PM

Post# of 257251
It seems that the crucial issue for FDA approval of Copaxone is if Momenta is able to show bioequivalence (which is almost impossible according to Teva). I do not see that the FDA will approve Copaxone without this even it has very well characterized their generic Copaxone.
What do you think or may be know?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today